Ellen Meara
@ermeara.bsky.social
Here for the health policy, economics, and more... Happy place: outside
July 13 Is Deadline To Comment On New Trump OMB Rule That Shifts Power www.forbes.com/sites/brucel...
July 13 Is Deadline To Comment On New Trump OMB Rule That Shifts Power
July 13 is the deadline to submit any public comments about the new White House OMB rule that would give the U.S. President Trump much more power over federal funding.
forbes.com
Although nearly 8 million Americans use Medicaid home and community-based services for long-term support, there is more to learn about the best ways to finance and deliver this care, from Jacob M. Sims Speyer, Ari Ne'eman, Norma B. Coe, and @ermeara.bsky.social www.nber.org/papers/w34701
Do you know someone who wants to learn about Health Policy PhD programs? Tell them to register for the Harvard Health Policy Admissions Info Session. Tuesday, 10/28/25 @ 2 pm Eastern.
I had the great privilege of interviewing @johncawley.bsky.social for the ASHEcon newsletter. Check out our discussion and several other great interviews in the fall edition of the newsletter! www.ashecon.org/category/new...
Newsletter Issue 2025:3 – ASHEcon
ashecon.org
John Cawley@johncawley.bsky.social · 10mo agoMany thanks to Jim Flynn @jimflynn9.bsky.social for interviewing me for the ASHEcon Newsletter @ashecon.bsky.social. It was fun to chat about risky health behaviors, priorities for ASHEcon, the #EconJobMarket, and even favorite movie/book/teams. #EconSky www.ashecon.org/activities/n...
Ben Sommers and I have a new piece up at @jamahealthforum.com on how to think about generalizing lessons from unwinding to looming new Medicaid red tape requirements. jamanetwork.com/journals/jam... We appreciate support from the @commonwealthfund.org for this work!
A new study from researchers at UNC found that only 32.7% of substance use disorder treatment facilities offered perinatal programs. Learn more about their findings here: buff.ly/RDZcx4U
The true cost of the reconciliation bill will be measured in lives—over 50,000 per year. It’s a predictable result when you cut off insurance to people who are old, poor and sick. Eric Roberts @pennldi.bsky.social and I discuss @msnbc.com @harvardhpm.bsky.social www.msnbc.com/opinion/msnb...
Opinion | The true cost of the GOP’s megabill will be measured in lives. Tens of thousands of lives.
It’s a predictable result when you cut off health insurance to people who are old, poor and sick.
msnbc.com
So excited to see Carolyn San Soucie present on health care utilization around age 19 Medicaid redetermination at @ashecon.bsky.social
HPM's Adrianna McIntyre chats with @wbur.org about potential implications of Medicaid cuts on children, work requirements, and more. @adrianna.bsky.social @hsph.harvard.edu
Why one family that relies on Medicaid has faith in President Trump
Families of infants and toddlers from around the country are in Washington, D.C. this week to tell lawmakers to protect Medicaid.
wbur.org
Eric Roberts and @joefigs.bsky.social led a groundbreaking new study on Medicaid and Medicare, out today in NEJM. I’m lucky to have been a part of it. Medicare saves lives. But is it enough to save lives of the most vulnerable Americans? The study suggests no; Medicaid still matters. (1/11)
Loss of Subsidized Drug Coverage and Mortality among Medicare Beneficiaries | NEJM
A total of 14 million Medicare beneficiaries receive the Low-Income Subsidy (LIS), which reduces cost sharing in Medicare Part D. Losing the LIS may impede medication access and affect mortality. U...
nejm.org
Veterans in Medicare Advantage and Traditional Medicare used dental and vision services at similar rates, with no significant difference in total spending. #SGIM25 https://ja.ma/3ZficKj
Excited to share new work in @jama.com on launch prices for cancer drugs in Medicare Part D. Prices are going up, but no trend change post-IRA. Mean monthly launch prices increased from $10,954 in 2012-2014 to $27,891 in 2023-2025. Many thanks to @arnoldventures.bsky.social for funding this work!
Trends in Launch Prices and Price Increases for Self-Administered Anticancer Drugs in Medicare
This study examines trends in launch prices and price increases for anticancer therapies covered under Medicare Part D and approved from 2010 to 2024.
jamanetwork.com
Loss of Subsidized Drug Coverage and Mortality among Medicare Beneficiaries | New England Journal of Medicine www.nejm.org/doi/full/10.... How important is help with drug costs? For dual Medicare-Medicaid beneficiaries, it saves lives.
Loss of Subsidized Drug Coverage and Mortality among Medicare Beneficiaries | NEJM
A total of 14 million Medicare beneficiaries receive the Low-Income Subsidy (LIS), which reduces cost sharing in Medicare Part D. Losing the LIS may impede medication access and affect mortality. U...
nejm.org
This interview and spending a day asking AI to “teach me” about a policy topic have me equally terrified + impressed. After AI gave clear bulleted answers to my questions and it ranked answers in importance, it offered to give me a playbook to persuade…
John Mullahy@johnmullahy.bsky.social · last yr.
**What has slowed health care spending growth in the U.S. over the past two decades?** www.nejm.org/doi/full/10....
The Value Zeitgeist — Considering the Slowdown in Health Care Spending Growth | NEJM
Over the past two decades, the health care spending growth rate in the United States has declined. But reducing the emphasis on value-based care could lead to a resurgence in spending growth.
nejm.org
The Value Zeitgeist — Considering the Slowdown in Health Care Spending Growth | New England Journal of Medicine www.nejm.org/doi/full/10.... @melindabbuntin.bsky.social , Carrie Colla, and I argue it's too soon to give up on value-based care.
The Value Zeitgeist — Considering the Slowdown in Health Care Spending Growth | NEJM
Over the past two decades, the health care spending growth rate in the United States has declined. But reducing the emphasis on value-based care could lead to a resurgence in spending growth.
nejm.org
New @nejm.org study with alarming results. The wealthiest Americans do not live as long as the wealthiest in other countries. In fact, mortality among the wealthiest Americans appeared to be similar to people in the poorest quartile in northern and western Europe. www.nejm.org/doi/full/10....
